Method of quantifying peptide-derivative libraries using phage display
The present application provides a method of quantifying an amount of a derivatized peptide displayed on a phage by phage display, the method comprising: providing a phage containing the target peptide thereon; reacting the phage containing the target peptide with a first reagent to derivatize the target peptide to form a derivatized peptide, reacting the derivatized peptide with a capture agent comprising a detection marker, thereby incorporating the detection marker within the derivatized peptide; and determining an amount of the detection marker, thereby quantifying the amount of the derivatized peptide displayed on the phage. A kit comprising a capture agent comprising a detection marker for quantifying the phage displayed derivatized peptides is also provided.
1. A method of quantifying an amount of a macrocyclic peptide displayed on a phage by phage display, the method comprising:
providing a phage containing a target peptide thereon;
reacting the phage containing the target peptide with a first reagent to derivatize the target peptide to form a derivatized peptide,
reacting the derivatized peptide with − C≡N + -biotin, thereby incorporating the − C≡N + -biotin within the derivatized peptide to form a macrocyclic peptide; and
determining an amount of the detection marker, thereby quantifying the amount of the macrocyclic peptide displayed on the phage.
2. A method of quantifying an amount of a derivatized peptide displayed on a phage by phage display, the method comprising:
providing a phage containing a target peptide displayed thereon;
reacting the phage containing the target peptide with a first reagent to derivatize the peptide to form a derivatized peptide,
reacting the derivatized peptide with a capture agent comprising a detection marker, thereby incorporating the detection marker within the derivatized peptide; and
determining an amount of the detection marker, thereby quantifying the amount of the derivatized peptide displayed on the phage, wherein the capture agent is biotin-aldehyde reactive probe (ARP).
3. The method of claim 2 , wherein the concentration of biotin-ARP is about 0.2-5 mM.
4. The method of claim 3 , wherein the concentration of biotin-ARP is about 0.2 mM, 1 mM, or 5 mM.